The efficacy of clarithromycin plus adalimumab versus clarithromycin plus placebo adalimumab for the treatment of Hidradenitis Suppurativa.

Trial Profile

The efficacy of clarithromycin plus adalimumab versus clarithromycin plus placebo adalimumab for the treatment of Hidradenitis Suppurativa.

Not yet recruiting
Phase of Trial: Phase II

Latest Information Update: 29 Apr 2014

At a glance

  • Drugs Adalimumab (Primary) ; Clarithromycin
  • Indications Hidradenitis suppurativa
  • Focus Therapeutic Use
  • Most Recent Events

    • 06 May 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top